Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma

Summary

This research study is evaluating a study drug to treat pancreatic exocrine insufficiency (PEI) during the first year after the diagnosis of pancreatic cancer while the participant is recovering from surgery and receiving adjuvant treatment. The study drug involved in this study is: -Zenpep

Timeline

Start

2018-04-13

Primary completion

2019-10-01

Completion

2019-10-01

Outcome

Outcome not reported

Stopped: “Sponsorship for trial was halted after company acquisition”

Drugs

Indications